Abstract
This short communication is aimed to update dental practitioners regarding the recently published warning of the U.S. Food and Drug Administration (FDA) regarding the risk for severe cardiovascular complications such as myocardial infarction or stroke following the use of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs).
Original language | English |
---|---|
Pages (from-to) | 6-10, 25 |
Journal | Refuat Hapeh Vehashinayim |
Volume | 32 |
Issue number | 4 |
State | Published - 1 Oct 2015 |
All Science Journal Classification (ASJC) codes
- General Medicine